Metallo-β
β-lactam antibiotics
β-lactam ring
β-lactam hydrolysis
serine β-lactamases
MBL inhibitors important
MBL inhibition
widespread occurrence of β
MBL structures
development of approaches
Lactamase Inhibitors
clinical use
synthesis of modified inhibitors
development of compounds
DCC
novel approaches
New Approaches
BLAs
important antibiotics
clinical utility
year
current mechanism-based SBL inhibitors
little clinical relevance
P-NMR reporter screening method
biological MS
major challenge
resistance mechanisms
representative MBLs
organic synthesis
use of phosphonates
proposed work
major global public health concern
related active sites
serious global threat
based combination therapies
increasing problem of antibiotic resistance
non-denaturing ESI-MS
penicillin-binding protein inhibition
generation of broad-spectrum MBLIs active
human enzymes
infections
structural biology
analysis
pre-equilibrated DCLs
breadth of selectivity necessary
multi-resistant bacterial pathogens
panel
clear need
euro
alarming situation
medicinal chemistry
phosphinic acids
small molecules
healthcare costs
desired objective
patients
variations
BLA efficacy
Society
study
aim
PBPs